Mallinckrodt (MNK) Tops Q4 EPS by 3c; Therakos Production Issues Noted
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
Go back to Mallinckrodt (MNK) Tops Q4 EPS by 3c; Therakos Production Issues Noted
November 29, 2016 9:52 AM EST
Mallinckrodt (NYSE: MNK) is seeing notable weakness following earning this morning. The call is ongoing. Shares are down 6.6%
...
More
November 29, 2016 9:43 AM EST
BMO Capital reiterated an Outperform rating and $92.00 price target on Mallinckrodt plc (NYSE: MNK) following the company's 4Q earnings report. Revenue of $887mn came in ahead of the consensus of 874mn, driven largely by Acthar. EPS were $2.04 vs. the consensus of 1.97.... More
November 29, 2016 8:46 AM EST
Mizuho Securities reiterated a Buy rating and $87.00 price target on Mallinckrodt plc (NYSE: MNK) following the company's 4Q earnings report. MNK reported revenues of $887.2M and adjusted EPS of $2.04, both ahead of consensus estimates of $832.1M and $1.90. Total branded sales of $633.1M outperformed consensus estimates of $596.6M.
Analyst Irina Koffler commented,... More
November 28, 2016 3:10 PM EST
Mallinckrodt (NYSE: MNK) December weekly 57 straddle priced for movement of 9.6%
...
More
